{"id":1216872,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Below-Knee Amputation - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T20:40:32.226000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53777.html?wbdisable=true","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Below-Knee Amputation A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) What is the issue? Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of drugs used in the second- or…","rawSnapshotUrl":"/api/snapshots/raw/1216872","browseUrl":"https://replay.healtharchive.ca/job-8/20260216204032/https://cihr-irsc.gc.ca/e/53777.html?wbdisable=true#ha_snapshot=1216872","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}